These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2423061)

  • 1. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1986 May; 104(5):694-701. PubMed ID: 2423061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Aug; 109(8):1109-14. PubMed ID: 1714270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1986 Apr; 104(4):503-12. PubMed ID: 2420315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial.
    Arch Ophthalmol; 1982 Jun; 100(6):912-8. PubMed ID: 7046707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argon laser photocoagulation for ocular histoplasmosis. Results of a randomized clinical trial.
    Arch Ophthalmol; 1983 Sep; 101(9):1347-57. PubMed ID: 6193771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
    Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
    Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1990 Jun; 108(6):832-7. PubMed ID: 1693498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argon laser photocoagulation for idiopathic neovascularization. Results of a randomized clinical trial.
    Arch Ophthalmol; 1983 Sep; 101(9):1358-61. PubMed ID: 6193772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1989 Mar; 107(3):344-52. PubMed ID: 2466454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1987 Nov; 105(11):1499-507. PubMed ID: 2445326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser treatment for choroidal neovascularization outside randomized clinical trials.
    Jost BF; Alexander MF; Maguire MG; Fine SL; Chamberlin JA; Murphy RP
    Arch Ophthalmol; 1988 Mar; 106(3):357-61. PubMed ID: 2449884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. The Canadian Ophthalmology Study Group.
    Arch Ophthalmol; 1993 Feb; 111(2):181-5. PubMed ID: 7679269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of ocular histoplasmosis treated by argon laser photocoagulation.
    Olk RJ; Fine SL; Scheraga D; Maguire M; Murphy RP; Patz A
    Retina; 1981; 1(3):238-44. PubMed ID: 7348843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of juxtafoveal and parafoveal neovascular membranes with monochromatic green argon photocoagulation: green laser.
    Orellana J; McPherson AR; Bravo JJ
    Ophthalmologica; 1987; 194(1):19-26. PubMed ID: 2438619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of xenon arc and argon laser photocoagulation in ocular histoplasmosis.
    Fine SL; Patz A
    Int Ophthalmol Clin; 1975; 15(3):259-84. PubMed ID: 1239427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photocoagulation of active and inactive lesions of presumed ocular histoplasmosis.
    Gitter KA; Cohen G
    Am J Ophthalmol; 1975 Mar; 79(3):428-36. PubMed ID: 1168416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.